September is Alzheimer’s Awareness Month, and in recognition of this Nova Cells Institute would like share some good news about how it is tackling this insidious condition and getting impressive results.
First off, the Nova Cells approach to treating Alzheimer’s disease takes into account the latest thinking among scientists and others on the disease processes that characterize it and how to interfere with and impede them.
So what processes do leading edge researchers think underlie Alzheimer’s disease? In-a-word AD is a protein misfolding disease (proteinopathy), caused by plaque accumulation of abnormally folded amyloid beta protein, and tau protein in the brain (Tauopathy), which form the neurofibrillary tangles which are a hallmark of the disease. Many scientists believe that AD is initiated by viruses, trauma, prions, inflammation or other factors.
Building on this, NCIM’s approach to combating AD includes:
- Countering aberrant prion activity and spread in the CNS.
- Significantly reducing neuroinflammation.
- Accelerating the digestion & elimination of misfolded proteins in neurons and other cells including hyperphosphorylated tau and alpha synuclein.
- A diet, supplement & drug regimen designed to improve cognition plus memory formation & recall.
But, Nova Cells goes the extra mile which boils down to this: While many stem cell medicine clinics just “throw” stem cells at Alzheimer’s disease (i.e. they give AD patients infusions of nonembryonic stem cells), Nova Cells offers a much more sophisticated & innovative approach to slowing progression and helping regain lost ground which includes https://ncimx.wordpress.com/2015/07/01/messed-up-cellular-garbage-disposal-system-found-to-play-a-role-in-alzheimers-disease-nova-cells-beacon-factor-coaxes-lysosomes-to-do-their-job/.
Ready to know more about NCIM and its stem cell treatment program for Alzheimer’s disease and other forms of dementia? Then call NCIM’s US information line at 1-562-916-3410 or email NCIM patient care facilitator/educator Grace Odgers, Ph.D. cand., by e-mail at email@example.com.